FENNEC PHARMACEUTICALS INC. — Director's Dealing 2025

Apr 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2025-03-28

Reporting Person: Hackman Jeffrey S. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-28	Restricted Share Unit	$0	A	75000	Acquired	2035-03-28	Common Shares (75000)	Direct
2025-03-28	Stock Options	$6.50	A	50000	Acquired	2035-03-28	Common Shares (50000)	Direct

Footnotes

F1: On March 28, 2025, Jeffrey Hackman was awarded restricted share units to acquire 75,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan

F2: One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction.

F3: On March 28, 2025, Jeffrey Hackman was granted incentive stock options to purchase 50,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.

F4: One-third of the shares subject to this option may be exercised as of March 28, 2026 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028, 100% of the total number of shares subject to this option shall be vested